Mallinckrodt ARD Inc., formerly known as Questcor Pharmaceuticals, Inc., and its parent company, Mallinckrodt plc, have agreed to pay $100 million to settle Federal Trade Commission charges that they violated the antitrust laws when Questcor acquired the rights to a drug that threatened its...
The Federal Trade Commission filed a complaint in federal district court charging Qualcomm Inc. with using anticompetitive tactics to maintain its monopoly in the supply of a key semiconductor device used in cell phones and other consumer products.
Hedge fund founder Ahmet H. Okumus has agreed to pay $180,000 in civil penalties to resolve Federal Trade Commission allegations that he violated the Hart-Scott-Rodino Act by failing to report his purchases of voting securities in the internet services company Web.com Group Inc.
The Federal Trade Commission staff submitted a supplemental comment and analysis to the Virginia Department of Health that opposes issuing a letter authorizing a cooperative agreement to Mountain States Health Alliance and Wellmont Health System.
The Federal Trade Commission and Department of Justice today issued revised Antitrust Guidelines for International Enforcement and Cooperation.
The Federal Trade Commission and the Department of Justice issued today updated Antitrust Guidelines for the Licensing of Intellectual Property that explain how the federal antitrust agencies evaluate licensing and related activities involving patents, copyrights, trade secrets, and know-how.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that CentraCare’s acquisition of St. Cloud Medical Group, also known as SCMG, would be anticompetitive.
The Federal Trade Commission staff submitted a supplemental comment and analysis to the Tennessee Department of Health that opposes issuing a certificate of public advantage, or COPA, to Mountain States Health Alliance and Wellmont Health System.
On April 18, 2017, the Federal Trade Commission will host a workshop to examine competition, innovation, and consumer protection issues raised by hearing health and technology, especially hearing aids.
It was another busy year for antitrust news. Here’s my look back at the top ten FTC-related antitrust developments for the year that was 2016 (in chronological order):
German pharmaceutical company Boehringer Ingelheim has agreed to divest five types of animal health products in the United States in order to settle FTC charges that its proposed asset swap with Paris-based Sanofi would likely be anticompetitive.
U.S.-based global healthcare company Abbott Laboratories has agreed to divest two medical device businesses to settle FTC charges that its proposed $25 billion acquisition of St. Jude Medical, Inc. would likely be anticompetitive.